ストックスクリーナーアプリを入手
1.04
33.13%
0.2588
アフターアワーズ：
1.00
-0.04
-3.85%
前日終値:
$0.7812
開ける：
$0.78
24時間の取引高:
13.77M
Relative Volume:
1.88
時価総額：
$33.88M
収益：
$950.10K
当期純損益:
$-16.69M
株価収益率:
-1.253
EPS:
-0.83
ネットキャッシュフロー:
$-15.16M
1週間 パフォーマンス:
+63.24%
1か月 パフォーマンス:
+39.19%
6か月 パフォーマンス:
-8.77%
1年 パフォーマンス:
-7.96%
1日の値動き範囲:
$0.78
$1.05
1週間の範囲:
$0.61
$1.05
52週間の値動き範囲:
$0.3067
$1.80
Femasys Inc Stock (FEMY) Company Profile
FEMY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
FEMY
Femasys Inc
|
1.04 | 33.60M | 950.10K | -16.69M | -15.16M | -0.83 |
|
ISRG
Intuitive Surgical Inc
|
560.00 | 194.19B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
177.84 | 50.84B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
251.49 | 36.44B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
ALC
Alcon Inc
|
73.97 | 36.72B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
271.04 | 19.81B | 2.96B | 487.70M | 344.00M | 6.6758 |
Femasys Inc (FEMY) 最新ニュース
Femasys gets FDA OK for final FemBloc trial, secures $12M financing, stock surges - MSN
Combining machine learning predictions for Femasys Inc.Market Rally & Weekly Market Pulse Updates - newser.com
Can Femasys Inc. stock reach $100 price targetEarnings Growth Summary & Growth-Oriented Investment Plans - newser.com
Is Femasys Inc. stock a safe haven assetEarnings Beat & AI Enhanced Trading Signals - newser.com
Is Femasys Inc. stock affected by interest rate hikesMarket Risk Summary & Daily Market Momentum Tracking - newser.com
What Wall Street predicts for Femasys Inc. stock price2025 Trade Ideas & Low Drawdown Trading Strategies - newser.com
Applying Wyckoff theory to Femasys Inc. stockJuly 2025 Pullbacks & Low Volatility Stock Suggestions - newser.com
Is Femasys Inc. trending in predictive chart modelsRate Hike & Verified Chart Pattern Signals - newser.com
Will Femasys Inc. stock continue upward momentumQuarterly Market Review & Community Consensus Trade Signals - newser.com
How resilient is Femasys Inc. stock in market downturns2025 Buyback Activity & Safe Capital Investment Plans - fcp.pa.gov.br
Why Femasys Inc. stock is considered a top pickIPO Watch & Risk Managed Investment Strategies - newser.com
Applying Elliott Wave Theory to Femasys Inc.Take Profit & Fast Momentum Entry Tips - newser.com
Does Femasys Inc. show high probability of reboundJuly 2025 EndofMonth & Fast Entry High Yield Stock Tips - newser.com
Exit strategy if you’re trapped in Femasys Inc.Weekly Loss Report & Consistent Return Strategy Ideas - newser.com
Is Femasys Inc. forming a bottoming baseQuarterly Growth Report & Expert Curated Trade Setups - newser.com
Femasys secures FDA approval to advance final FemBloc trial phase - MSN
Will Femasys Inc. stock benefit from commodity pricesEarnings Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com
What margin trends mean for Femasys Inc. stockTrade Ideas & High Accuracy Swing Entry Alerts - newser.com
What to do if you’re stuck in Femasys Inc.2025 Investor Takeaways & Weekly High Return Stock Opportunities - newser.com
FDA approves Femasys to continue pivotal trial for non-surgical birth control - Investing.com Australia
Femasys Stock Sparks Retail Frenzy After FDA Clears Final Phase Of FemBloc Trial And $58M Financing - MSN
Femasys surges on Fembloc FDA approval, $58 million funding news | Tap to know more | Inshorts - Inshorts
Femasys Secures Fda Approval to Advance Final Fembloc Trial Phase and $12 Million Financing, with Potential to Reach $58 Million - MarketScreener
Femasys Inc. announced that it expects to receive $12 million in funding - MarketScreener
Femasys (FEMY) Skyrockets on Breakthrough Birth Control Trial News – Is This Women’s Health Innovator a Game-Changer? - ts2.tech
Femasys Receives FDA Approval for FemBloc Trial - TipRanks
Femasys Inc Secures FDA Approval for Final FemBloc Trial Phase - TradingView
Femasys Inc. Advances FemBloc Toward FDA Approval with Successful Trial Completion and $12 Million Financing - Quiver Quantitative
Femasys Secures FDA Approval to Advance Final FemBloc® Trial Phase and $12 Million Financing, with Potential to Reach $58 Million - The Manila Times
Femasys Secures FDA Approval to Advance Final FemBloc® Trial Phase and $12 Million Financing, ... - Caledonian Record
Femasys (NASDAQ: FEMY) to issue $12M notes; warrants lift total potential to $58M - Stock Titan
Femasys Meets Nasdaq Equity Requirement After Offering - MSN
Custom watchlist performance reports with Femasys Inc.Earnings Overview Summary & Accurate Buy Signal Notifications - newser.com
Femasys Inc (FEMY) 財務データ
収益
当期純利益
現金流量
EPS
0.11%
0.07%
大文字化:
|
ボリューム (24 時間):